Mostrar el registro sencillo del ítem

dc.contributor.authorFrenkel-Morgenstern, Milana
dc.contributor.authorGorohovski, Alessandro
dc.contributor.authorVucenovic, Dunja
dc.contributor.authorMaestre L, Lorena 
dc.contributor.authorValencia, Alfonso 
dc.date.accessioned2020-05-12T16:20:07Z
dc.date.available2020-05-12T16:20:07Z
dc.date.issued2015-01
dc.identifier.citationNucleic Acids Res. 2015;43(Database issue):D68-75es_ES
dc.identifier.issn1362-4962es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/10088
dc.descriptionMiguel Servet (FIS: CP11/00294) [to M.F.-M. for staff scientists]. Funding for open access charge: NHGRI-NIH ENCODE [HG00455-04]; Blueprint European Union project [282510]; Spanish Government [BIO2007-66855]; Spanish National Bioinformatics Institute (INB-ISCIII), Genecode/ENCODE NHGRI-NIH [HG00455-04].es_ES
dc.description.abstractChimeric RNAs that comprise two or more different transcripts have been identified in many cancers and among the Expressed Sequence Tags (ESTs) isolated from different organisms; they might represent functional proteins and produce different disease phenotypes. The ChiTaRS 2.1 database of chimeric transcripts and RNA-Seq data (http://chitars.bioinfo.cnio.es/) is the second version of the ChiTaRS database and includes improvements in content and functionality. Chimeras from eight organisms have been collated including novel sense-antisense (SAS) chimeras resulting from the slippage of the sense and anti-sense intragenic regions. The new database version collects more than 29,000 chimeric transcripts and indicates the expression and tissue specificity for 333 entries confirmed by RNA-seq reads mapping the chimeric junction sites. User interface allows for rapid and easy analysis of evolutionary conservation of fusions, literature references and experimental data supporting fusions in different organisms. More than 1428 cancer breakpoints have been automatically collected from public databases and manually verified to identify their correct cross-references, genomic sequences and junction sites. As a result, the ChiTaRS 2.1 collection of chimeras from eight organisms and human cancer breakpoints extends our understanding of the evolution of chimeric transcripts in eukaryotes as well as their functional role in carcinogenic processes.es_ES
dc.language.isoenges_ES
dc.publisherOxford University Press es_ES
dc.type.hasVersionVoRes_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.subject.meshAnimals es_ES
dc.subject.meshChromosome Breakpoints es_ES
dc.subject.meshExpressed Sequence Tags es_ES
dc.subject.meshHumans es_ES
dc.subject.meshInternet es_ES
dc.subject.meshMice es_ES
dc.subject.meshRNA, Antisense es_ES
dc.subject.meshRNA, Messenger es_ES
dc.subject.meshSequence Analysis, RNA es_ES
dc.subject.meshDatabases, Nucleic Acides_ES
dc.titleChiTaRS 2.1--an improved database of the chimeric transcripts and RNA-seq data with novel sense-antisense chimeric RNA transcriptses_ES
dc.typejournal articlees_ES
dc.rights.licenseAtribución-NoComercial-CompartirIgual 4.0 Internacional*
dc.identifier.pubmedID25414346es_ES
dc.format.volume43es_ES
dc.format.numberDatabase issuees_ES
dc.format.pageD68-75es_ES
dc.identifier.doi10.1093/nar/gku1199es_ES
dc.contributor.funderNHGRI-NIH ENCODE
dc.contributor.funderHG00455-04 Blueprint European Union project
dc.contributor.funderUnión Europea 
dc.description.peerreviewedes_ES
dc.identifier.e-issn1362-4962es_ES
dc.relation.publisherversionhttps://doi.org/ 10.1093/nar/gku1199.es_ES
dc.identifier.journalNucleic acids researches_ES
dc.repisalud.institucionCNIOes_ES
dc.repisalud.orgCNIOCNIO::Unidades técnicas::Unidad de Anticuerpos Monoclonaleses_ES
dc.relation.projectIDinfo:eu_repo/grantAgreement/ES/CP11/00294es_ES
dc.rights.accessRightsopen accesses_ES


Ficheros en el ítem

Acceso Abierto
Thumbnail
Acceso Abierto

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución-NoComercial-CompartirIgual 4.0 Internacional
Este Item está sujeto a una licencia Creative Commons: Atribución-NoComercial-CompartirIgual 4.0 Internacional